PNC Financial Services Group’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$16K Buy
550
+450
+450% +$13.1K ﹤0.01% 3782
2025
Q4
$2.62K Hold
100
﹤0.01% 4463
2025
Q3
$2.36K Hold
100
﹤0.01% 4452
2025
Q2
$2.05K Hold
100
﹤0.01% 4399
2025
Q1
$2.05K Hold
100
﹤0.01% 4336
2024
Q4
$2.26K Hold
100
﹤0.01% 4252
2024
Q3
$2.46K Hold
100
﹤0.01% 4241
2024
Q2
$2.31K Hold
100
﹤0.01% 4221
2024
Q1
$2.41K Hold
100
﹤0.01% 4156
2023
Q4
$2.3K Hold
100
﹤0.01% 4166
2023
Q3
$2.04K Sell
100
-602
-86% -$13.5K ﹤0.01% 4241
2023
Q2
$16.4K Hold
702
﹤0.01% 3638
2023
Q1
$16.3K Sell
702
-155
-18% -$3.88K ﹤0.01% 3589
2022
Q4
$21.6K Hold
857
﹤0.01% 3429
2022
Q3
$23K Hold
857
﹤0.01% 3380
2022
Q2
$25K Sell
857
-800
-48% -$23.9K ﹤0.01% 3378
2022
Q1
$57K Buy
1,657
+427
+35% +$15.1K ﹤0.01% 3031
2021
Q4
$54K Hold
1,230
﹤0.01% 3066
2021
Q3
$62K Buy
1,230
+550
+81% +$28.7K ﹤0.01% 2935
2021
Q2
$35K Buy
680
+190
+39% +$8.92K ﹤0.01% 3241
2021
Q1
$22K Buy
+490
New +$23.9K ﹤0.01% 3368

Other funds holding IDNA

PNC Financial Services Group's IDNA Position: Q1 2026 in Review

PNC Financial Services Group increased its iShares Genomics Immunology and Healthcare ETF (IDNA) stake by 450% in Q1 2026, buying an estimated $13.1K and bringing the position to 550 shares worth $16K. The position accounts for ﹤0.01% of the portfolio, ranked #3782.

PNC Financial Services Group first reported a position in IDNA in Q1 2021 and has held it in 21 quarters since. The position peaked at $62K in Q3 2021. 60 funds tracked by Wall St. Rank hold IDNA as of Q1 2026.

  • PNC Financial Services Group held 550 shares of iShares Genomics Immunology and Healthcare ETF worth $16K as of Q1 2026.
  • PNC Financial Services Group bought 450 iShares Genomics Immunology and Healthcare ETF shares in Q1 2026, an estimated $13.1K.
  • iShares Genomics Immunology and Healthcare ETF made up ﹤0.01% of PNC Financial Services Group's portfolio in Q1 2026, its #3782 holding.
  • PNC Financial Services Group first reported a position in iShares Genomics Immunology and Healthcare ETF in Q1 2021 and has held it in 21 quarters since.
  • PNC Financial Services Group's iShares Genomics Immunology and Healthcare ETF position peaked at $62K in Q3 2021.
  • 60 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q1 2026.

Based on PNC Financial Services Group's 13F filing for Q1 2026, filed 8 May 2026.